πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

1,257 results for β€œFirst” Clear

  1. the ginsenoside Rg3

    The First People's Hospital of Lianyungang

    Stage I Hepatocellular Carcinoma

    small molecule completed

    1 trial
  2. thyroxine

    The First People's Hospital of Lianyungang

    Hypothyroidism

    small molecule completed

    1 trial
  3. traditional chinese medicine Xuanfei-Zhike formula

    The First People's Hospital of Lianyungang

    Cough Variant Asthma

    small molecule active

    1 trial
  4. vats

    The First People's Hospital of Lianyungang

    NSCLC

    other active

    1 trial
  5. xDRIVE Tumor Profiling

    The First People's Hospital of Lianyungang

    Cancer

    other active

    1 trial
  6. zanubrutinib 160 mg BID orally

    The First People's Hospital of Lianyungang

    Primary Central Nervous System Lymphoma

    small molecule active

    1 trial
  7. zanubrutinib, bendamustine, and obinutuzumab

    The First People's Hospital of Lianyungang

    Follicular Lymphoma

    small molecule active

    1 trial
  8. zuojinwan

    The First People's Hospital of Lianyungang

    Functional Dyspepsia

    small molecule active

    1 trial
  9. Ξ³-globin reactivated autologous hematopoietic stem cells

    The First People's Hospital of Lianyungang

    Thalassemia Major

    mab on hold

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources